Position
CERTUITY, LLC in Regeneron Pharmaceuticals, Inc.
Back to the book · All holders of REGN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$42$772.41 → $772.33
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 637 | $492K | — | — | — | 0.0% |
| Q1 2026 | 519 | $400.8K | $772.33 | −$42 | −$91.1K | 0.0% |